Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell membrane lipid domains, commonly known as lipid rafts, are specialized, dynamic microdomains enriched in cholesterol, sphingolipids, and specific proteins like glycosylphosphatidylinositol (GPI)-anchored proteins (Simons & Toomre, 2000). These domains function as organizing centers for signal transduction by concentrating or segregating signaling molecules, thereby facilitating efficient cellular responses to external stimuli (Pike, 2006). They play critical roles in various biological processes, including vesicular trafficking, endocytosis, and the assembly of signaling complexes for immune receptors (Lingwood & Simons, 2010). In disease states, lipid domains are often hijacked; for instance, they serve as entry points for pathogens like HIV and SARS-CoV-2 and act as sites for the production of amyloid-beta in Alzheimer's disease (Michel & Bakovic, 2007). Pharmacological targeting of these domains, a strategy known as membrane lipid therapy, involves using agents that alter lipid composition or organization to disrupt aberrant signaling in cancer or prevent viral infection (Mollinedo & Gajate, 2015). Drugs like edelfosine and miltefosine specifically target these domains to induce apoptosis in malignant cells while sparing normal tissues (Escribá et al., 2015). Additionally, cholesterol-depleting agents like methyl-beta-cyclodextrin are widely used in research to study the functional importance of these domains in cellular physiology (Zidovetzki & Levitan, 2007).
Modulation of membrane lipid composition and physical properties to disrupt or stabilize signaling platforms, often through cholesterol depletion, sphingolipid interaction, or alteration of membrane fluidity (Mollinedo & Gajate, 2015; Escribá et al., 2015).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell membrane lipid domain.